Addis Ababa University: The first step to successfully treating a disease is accurate diagnosis. IDRI is working with collaborators at Addis Ababa University to develop the next generation diagnostic to diagnose forms of leishmaniasis that are specific to that region in Africa.
INDIA: Where is the best place to produce vaccines to prevent infectious diseases? At IDRI, we believe it’s in the countries where they are needed most. To produce products that will be used to combat deadly diseases in India, IDRI partnered with Gennova Pharmaceuticals to build a facility and transfer IDRI technology to produce antigen and/or adjuvant formulations for vaccines to combat malaria, tuberculosis and leishmaniasis.
OrangeLife: In Brazil, the bite of a tiny sand fly can change a life – causing a debilitating disease called leishmaniasis. Our partners in Brazil, OrangeLife, used IDRI technology to develop a rapid diagnostic test for leishmaniasis, as well as leprosy, another disease prevalent in Brazil. Early detection and effective vaccines – also being developed by IDRI scientists – can bring these diseases under control.
Deadly co-infections of HIV/AIDS and TB are problematic around the world, but particularly in Africa. Key to stopping TB is developing a vaccine. IDRI is partnering with the South African Tuberculosis Vaccine Initiative, part of the University of Cape Town, to move toward this goal by conducting additional clinical trials there.
Infectious Disease Research Institute